Home
    Timetable
    Registration
    Accommodation
    Contact
Home
Welcome Note
Committees
Timetable
Preliminary Topics
List of Faculty
Scientific Program
Anterior Segment Section
Retina Section
Glaucoma Section
Neuro-Ophthalmology
Pediatrics
Surgical Marathon
Symposia
Poster Presentations
Group A
Group B
Poster Presentation Guidelines
Sponsorship & Exhibition
Sponsors
Registration
Invitation Letter
Accommodation
Swissôtel The Bosphorus
CME
General Information
Before you travel...
Italian Agent
Chinese Agent
Transportation
About Istanbul
Partners
Previous Congresses
COPHy 2010
COPHy 2011
The 3rd World Congress on
Controversies in Ophthalmology (COPHy)
Anterior Segment, Retina, Glaucoma

Istanbul, Turkey, March 22 - 25, 2012
  Retina Section Print
 
Friday, March 23, 2012
 
Retina I
Controversies Regarding Treatment of Non-Neovascular AMD
Room: Fuji 1
08:30-10:00
Chairpersons: S. Bressler, USA & A. Loewenstein, Israel
 
Capsule: Rapid-fire discussion
08:30-08:45
08:30-08:35
08:35-08:40
08:40-08:45
 
Dietary supplements such as those used in AREDs should not be recommended for people with geographic atrophy in each eye
Yes: P. Lanzetta, Italy
No: A. Loewenstein, Israel
Final disucssion with Panel: All Speakers
  
08:45-09:00
 
08:45-08:50
08:50-08:55
08:55-09:00
50 year-old children of parents in which both parents have advanced AMD (disciform scars) in both eyes and in which the children have no large drusen in both eyes should take dietary supplements
Yes: F. Bandello, Italy
No: S. Bressler, USA
Final disucssion with Panel
 
09:00-09:15
 
09:00-09:05
09:05-09:10 
09:10-09:15
A diet rich in green leafy vegetables, or sunglasses, or both, should specifically be recommended to patients with large drusen in both eyes
Yes: B. Eldem, Turkey
No: N. Bressler, USA
Final discussion with Panel
  
09:15-09:30
 
09:15-09:20
09:20-09:25
09:25-09:30
People aged 50 years of age and lder with no drusen in both eyes should have genetic screening for age-related macular degeneration
Yes: G. Soubrane, France
No: W. Mieler, USA
Final discussion with Panel
  
09:30-09:45
 
  
09:30-09:40
09:40-09:45
People with large drusen in both eyes should use an Amsler grid in each eye each day to monitor for the potential development of choroidal neovascularization
Yes & No: A. Loewenstein, Israel
Final discussion with Panel
  
09:45-10:00
 
09:45-09:50
09:50-09:55
09:55-10:00
People with large drusen in both eyes are at increased risk of progessing to choroidal neovascularization or geographic atrophy or both following cataract surgery
Yes: Y. Durlu, Turkey
No: J. Mones, Spain
Final discussion with Panel
   
Retina II
Controversies Regarding Management of Macular Edema from Retinal Vein Occlusions
Room: Fuji 1
10:30-12:00
Chairpersons: F. Bandello, Italy & G. Coscas, France
    
Capsule: Branch vein occlusion and macular edema - multiple optional treatments
10:30-10:40
  
10:40-10:45
 
10:45-10:55
 
10:55-11:00
 
11:00-11:10
  
11:10-11:15
 
Ranibizumab or Bevacizumab monthly for 6 months
F. Bandello, Italy
Q&A from the audience, panel, chairpersons
  
Ranibizumab or Bevacizumab PRN
P. Lanzetta, Italy
Q&A from the audience, panel, chairpersons
  
Iluvien or Ozurdex
J. Mones, Spain
Q&A from the audience, panel, chairpersons 
11:15-12:00
Roundtable discussion
1) First-line therapy when finance is not an issue (a. Ranibizumab, b. Bevacizumab, c. VEGF-trap, fixed regimen or PRN for first 6 months, d. Ozurdex)
2) After 6 months (a. Ranibizumab PRN, Bevacizumab PRN, VEGF-trap PRN, b. Add grid laser, c. Add grid laser only if anti-VEGF does not work, d. Ozurdex)
Moderator: F. Bandello, Italy
Panel:
S. Arf, Turkey
G. Coscas, France
E. Cunha de Souza, Brazil
O. Gelisken, Turkey
J. Mones, Spain
 
       
Retina III
Controversies on Imaging: Autofluorescence, OCT
Room: Fuji 1
14:00-15:30
Chairpersons: J. Cunha-Vaz, Portugal & U. Schmidt-Erfurth, Austria
    
Capsule: Imaging in the present and future
14:00-14:15
  
14:15-14:25
   
14:25-14:35
   
14:35-14:40
 
14:40-14:50
  
14:50-14:55
   
14:55-15:30
 
Autofluorescence: Pros and Cons
H. Scholl, USA
Q&A from the audience, panel, chairpersons
 
SD OCT leads to different outcomes than TD OCT
U. Schmidt-Erfurth, Austria
Q&A from the audience, panel, chairpersons
 
SD OCT does not lead to different outcomes than TD OCT
S. Bressler, USA
Q&A from the audience, panel, chairpersons
 
Discussion
Moderator: H. Scholl, USA
Panel:
S. Bressler, USA
J. Cunha-Vaz, Portugal
U. Schmidt-Erfurth, Austria
       
Retina IV
Tumor: Melanoma, Retinoblastoma, Lymphoma
Room: Fuji 1
17:00-18:30
Chairperson: B. Damato, UK
 
17:00-17:30
17:00-17:10
 
17:10-17:20
   
17:20-17:30
 
17:30-18:00
17:30-17:40
   
17:40-17:50
 
17:50-18:00
 
18:00-18:30
18:00-18:10
 
18:10-18:20
   
18:20-18:30
Debate I: Supra intra-arterial chemotherapy
Pro
H. Kiratli, Turkey
Con
K. Gunduz, Turkey
Discussion
 
Debate II: FNAB in uveal melanoma
Pro
B. Damato, UK
Con
H. Kiratli, Turkey
Discussion
 
Debate III: Treatment of vitreo-retinal lymphoma
In favor of intravitreal injections of methotrexate
B. Damato, UK
In favor of other modalities (systemic chemotherapy and irradiation)
K. Gunduz, Turkey
Discussion
     
 
Saturday, March 24, 2012
 
Retina V
Controversies in Treatment of Diabetic Macular Edema
Fuji 1
08:30-10:00
Chairpersons: B. Eldem, Turkey & G. Soubrane, France
      
Capsule: Management of diabetic retinopathy in 2012
08:30-08:40
   
08:40-08:45
 
08:45-08:55
 
08:55-09:00
 
09:00-09:10
 
09:10-09:15
 
09:15-10:00
Focal Grid laser
G. Soubrane, France
Q&A from the audience, panel, chairpersons
 
Anti-VEGF therapy (e.g. DRCR Network Algorithm)
S. Bressler, USA
Q&A from the audience, panel, chairpersons
 
Other tretaments (e.g. combination therapy)
B. Eldem, Turkey
Q&A from the audience, panel, chairpersons
 
Roundtable discussion
Is it time to give up in DME: a. Fluorescein angiography, b. Diffuse vs. Focal terminology, c. Clinically significant macular edema terminology, d. Standard fundus photography, f. Wide-field fundus photography or fluorescein angiography, g. Contact lens biomicroscopy, h. Laser wavelength, i. Subthreshold laser, j. Suprathreshold laser, k. Short acting drugs, l. Long acting drugs?
Moderator: F. Bandello, Italy
Panel:
S. Arf, Turkey
S. Bressler, USA
E. Cunha de Souza, Brazil
J. Cunha-Vaz, Portugal
B. Eldem, Turkey
G. Soubrane, France
      
Retina VI
Surgery: Innovations
Room: Fuji 2
11:30-12:45
Chairpersons: W. Mieler, USA
   
Capsule: New technologies and old problems
11:30-12:00
Debate I: The best treatment for vitreoretinal interface disorders (Macular hole, vitreomacular traction, lameller holes)
11:30-11:40
 
11:40-11:50
  
11:50-12:00
   
  
12:00-12:30
12:00-12:10
  
12:10-12:20
The natural history warrants observation
F. Boscia, Italy
Vitrectomy should be performed
S. Rizzo, Italy
Microplasmin
W. Mieler, USA 
    
Debate II: The interface of Cataract surgery and Vitrectomy
Vitrectomy for retained lens fragments – indications, techniques and outcome
J. Nawrocki, Poland
Vitrectomy for dislocated IOLS – timing, techniques and refractive options

12:20-12:30
A. Buchholz, Germany
The pros and cons for performing concurrent cataract surgery in patients
 
    
  
12:30-12:45
 
undergoing posterior vitrectomy
S. Rizzo, Italy
     
Case presentations and Panel discussion
(2-3 cases)
Presenter: W. Mieler, USA
Panel:
F. Boscia, Italy
S. Kadayifcilar, Turkey
M. Karacorlu, Turkey
J. Nawrocki, Poland
S. Rizzo, Italy
G. Yilmaz, Turkey
       
Retina VII
Trauma: Orbital, Outer & Posterior Segment
Room: Fuji 1
16:15-17:30
Chairperson: W. Schrader, Germany
 
Capsule:
16:15-16:30
 
 
16:30-17:10
  
16:30-16:45
 
16:45-17:00
17:00-17:10
 
17:10-17:30
New technologies and old problems
Lecture: Combined anterior and posterior segment reconstruction
W. Schrader, Germany
     
Debate: Removal of IOFB - Timing and surgical approach
Pro: Immediate removal of the IOFB is critical
A. Nikolakopoulos, Greece
Con: Delayed removal is safe
W. Mieler, USA
Discussion
  
Case presentations and Panel discussion: Posterior segment trauma
Moderators: W. Schrader, Germany
Panel:
A. Barak, Israel
B. Eldem,Turkey
M. Karacorlu, Turkey
W. Mieler, USA 
A. Nikolakopoulos, Greece
G. Sobaci, Turkey
             

Home   
Copyright © 2008 Comtecmed.com. All rights reserved.   The website was last updated on 12/03/2012 Created by    WebStudio.co.il